TrialSpark logo
TrialSpark is rebranding to Formation Bio, effective December 5, 2023. Click here to learn more.
Download our white paper.

React, Adapt, Evolve: Clinical Trials During and Beyond COVID-19

Our white paper explores TrialSpark’s core areas of focus during the COVID-19 pandemic.

doctors-and-crcs

Ensuring continuity of clinical research during COVID-19

Within each focus area below, we offer specific solutions implemented in response to COVID-19 and flag proactive steps to improve efficiency and flexibility in future protocols.

  • Patient Engagement

    Patient Engagement

  • COVID 19 White Paper Landing Page - Site-level oversight

    Site-level oversight

  • Clinical Assessments

    Clinical Assessments

  • Drug IP

    Patient Drug Supply

  • Data Management

    Data Management

Download our white paper to learn more.